FIELD: medicine.
SUBSTANCE: for detecting thrombinemia associated with large joint replacement, on the 10th-14th postoperative day, patient's blood plasma is examined for the hemostasis system values: the concentrations of D-dimer, plasminogen and antithrombin III. A discriminator (Z) is calculated by formula: Z=4.3936-0.001×D-0.029×P+0.017×A, where D is the concentration of D-dimer (ng/ml FEU), P is the concentration of plasminogen (percentage of normal concentration), A is the concentration of antithrombin (percentage of normal concentration). If observing the value Z <0, high probability of preserving thrombinemia is diagnosed, and pharmacological antithrombotic prevention is recommended to be continued.
EFFECT: use of the declared method allows high-efficient determination of appropriateness of prolongation of a pharmacological antithrombotic prevention course following the large joint replacement.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THROMBOEMBOLIC COMPLICATIONS PREDICTION | 2016 |
|
RU2621298C1 |
METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2794035C1 |
METHOD FOR OPTIMIZING LABORATORY DIAGNOSIS OF THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2789822C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HBV- AND HCV-INFECTION IN PATIENTS WITH LIVER CIRRHOSIS | 2010 |
|
RU2444997C1 |
METHOD FOR PREDICTING PULMONARY ARTERIAL EMBOLIZATION IN ONCOLOGY PATIENTS WITH LOWER EXTREMITY PHLEBOTHROMBOSIS | 2016 |
|
RU2664448C2 |
METHOD FOR DETECTING HYPERCOAGULATION AND INTRAVASCULAR COAGULATION ACTIVATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA IN MANIFESTATION | 2012 |
|
RU2497127C1 |
METHOD FOR ASSESSING STATE OF HEMOSTASIS | 2023 |
|
RU2817000C1 |
METHOD OF TREATING ACUTE VENOUS THROMBOSES OF VARIOUS LOCALISATIONS WITH UNDERLYING HEMORRHAGIC COMPLICATIONS | 2012 |
|
RU2477636C1 |
METHOD FOR ASSESSING RISK OF BLEEDING DURING AND AFTER DENTAL INTERVENTIONS IN PATIENTS TAKING ORAL ANTICOAGULANTS | 2023 |
|
RU2813439C1 |
METHOD FOR DETECTING ANTITHROMBOTIC BLOOD VESSEL ACTIVITY WEAKENING AT EARLY STAGE | 2006 |
|
RU2316765C1 |
Authors
Dates
2011-07-10—Published
2009-10-05—Filed